论文部分内容阅读
通过对83例分娩后1-4天的哺乳期妇女予催产素注射液滴鼻,并设对照组(生理盐水滴鼻)进行效果观察。结果表明:催产素滴鼻的乳母较滴生理盐水液的乳母泌乳始动时间提早(x2=14.82,P<0.01),且泌乳量明显增多(x2=16.47,P<0.01)。B超下显示:滴鼻后10分钟测左乳腺腺管直径为0.4872±0.083cm,左侧乳腺腺管直径用药前、后比较t=14.08,P<0.01。而对照组乳腺腺管直径用药前后比较,P>0.05,无显著差异。说明催产素滴鼻后使乳腺腺管明显扩张,肌上皮收缩,从而起促泌乳作用。此法方便安全,无副作用,可在临床推广使用。
Through the 83 cases of 1-4 days after delivery lactating women to oxytocin nasal drops, and the control group (saline drip) for observation. The results showed that oxytocin nasal lactation started earlier (x2 = 14.82, P <0.01), and lactation volume increased significantly (x2 = 16.47, P <0) .01). B ultrasound showed that the diameter of the left breast duct was 0.4872 ± 0.083 cm 10 minutes after the nasal drops, the diameter of the left breast duct was t = 14.08 before and after treatment, P <0.01. The control group breast duct diameter before and after treatment, P> 0.05, no significant difference. Oxytocin intranasal injection of oxytocin significantly expand the ducts, myoepithelial contraction, which played a role in promoting lactation. This method is convenient and safe, no side effects, can be used in clinical promotion.